ArticleDigestive diseases and sciences2018

Immunephenotype Predicts Response to Vedolizumab: Integrating Clinical and Biochemical Biomarkers in the Treatment of Inflammatory Bowel Diseases.

Stefano Fiorucci et al.PubMed ↗Publisher ↗

No numbers read from the abstract.